New chemo combos show promise for hard-to-treat bile duct cancer
Disease control
Completed
This study tested two different chemotherapy combinations in 93 people with advanced bile duct cancer that could not be removed by surgery. The goal was to see which combination worked better at slowing cancer growth. Participants received either nal-IRI with 5-FU and leucovorin,…
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated May 15, 2026 11:57 UTC